Advanced Enzyme Tech growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+17.1%+11.3%
EBITDA+17.8%+13.6%
Net Income+29.6%+18.7%
EPS (adj.)+28.7%+16.9%
Total Assets+13.4%+8.9%
Total Equity+14.6%+9.4%
Free Cash Flow−3.1%+0.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ADVENZYMES₹264.15

Advanced Enzyme Tech Ltd.

· Pharma & Health
₹ CrorePeersAARTIPHARMAARTIDRUGSAGARWALEYEAKUMSALIVUSAPLLTDCORONAHCGMcap ₹2,956 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+17.1+11.3
EBITDA+17.8+13.6
Net Income+29.6+18.7
EPS (adj.)+28.7+16.9
Total Assets+13.4+8.9
Total Equity+14.6+9.4
Free Cash Flow-3.1+0.7
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.